332 related articles for article (PubMed ID: 24657241)
1. Role of statins in the treatment of multiple sclerosis.
Ciurleo R; Bramanti P; Marino S
Pharmacol Res; 2014 Sep; 87():133-43. PubMed ID: 24657241
[TBL] [Abstract][Full Text] [Related]
2. Statins and demyelination.
Weber MS; Zamvil SS
Curr Top Microbiol Immunol; 2008; 318():313-24. PubMed ID: 18219823
[TBL] [Abstract][Full Text] [Related]
3. Are statins a treatment option for multiple sclerosis?
Neuhaus O; Stüve O; Zamvil SS; Hartung HP
Lancet Neurol; 2004 Jun; 3(6):369-71. PubMed ID: 15157852
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis.
Neuhaus O; Hartung HP
Expert Rev Neurother; 2007 May; 7(5):547-56. PubMed ID: 17492904
[TBL] [Abstract][Full Text] [Related]
5. Statin treatment in multiple sclerosis: a systematic review and meta-analysis.
Pihl-Jensen G; Tsakiri A; Frederiksen JL
CNS Drugs; 2015 Apr; 29(4):277-91. PubMed ID: 25795002
[TBL] [Abstract][Full Text] [Related]
6. Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate.
Neuhaus O; Stüve O; Archelos JJ; Hartung HP
J Neurol Sci; 2005 Jun; 233(1-2):173-7. PubMed ID: 15949504
[TBL] [Abstract][Full Text] [Related]
7. Statins as potential therapeutic agents in neuroinflammatory disorders.
Stüve O; Youssef S; Steinman L; Zamvil SS
Curr Opin Neurol; 2003 Jun; 16(3):393-401. PubMed ID: 12858078
[TBL] [Abstract][Full Text] [Related]
8. Statins--treatment option for central nervous system autoimmune disease?
Weber MS; Steinman L; Zamvil SS
Neurotherapeutics; 2007 Oct; 4(4):693-700. PubMed ID: 17920550
[TBL] [Abstract][Full Text] [Related]
9. [Cholesterol-reducing medications-a new therapeutic option for multiple sclerosis? Statins as immunomodulators].
Neuhaus O; Wiendl H; Kieseier BC; Archelos JJ; Hartung HP
Nervenarzt; 2003 Aug; 74(8):704-7. PubMed ID: 12904873
[TBL] [Abstract][Full Text] [Related]
10. Drug Insight: using statins to treat neuroinflammatory disease.
Weber MS; Prod'homme T; Steinman L; Zamvil SS
Nat Clin Pract Neurol; 2005 Dec; 1(2):106-12. PubMed ID: 16932506
[TBL] [Abstract][Full Text] [Related]
11. Statins: potential new indications in inflammatory conditions.
Endres M
Atheroscler Suppl; 2006 Apr; 7(1):31-5. PubMed ID: 16503422
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects of statins and autoimmune rheumatic diseases: novel intracellular mechanism involved.
Tristano AG; Fuller K
Int Immunopharmacol; 2006 Dec; 6(12):1833-46. PubMed ID: 17052674
[TBL] [Abstract][Full Text] [Related]
13. The combination of interferon-beta and HMG-CoA reductase inhibition in multiple sclerosis: enthusiasm lost too soon?
Sellner J; Weber MS; Vollmar P; Mattle HP; Hemmer B; Stüve O
CNS Neurosci Ther; 2010 Dec; 16(6):362-73. PubMed ID: 20626428
[TBL] [Abstract][Full Text] [Related]
14. Toward a role for statins in immunomodulation.
Mach F
Mol Interv; 2002 Dec; 2(8):478-80. PubMed ID: 14993398
[TBL] [Abstract][Full Text] [Related]
15. Influence of statins on MHC class I expression.
Singh P; Kohr D; Kaps M; Blaes F
Ann N Y Acad Sci; 2009 Sep; 1173():746-51. PubMed ID: 19758224
[TBL] [Abstract][Full Text] [Related]
16. Statins as potential therapeutic agents in multiple sclerosis.
Stüve O; Prod'homme T; Youssef S; Dunn S; Neuhaus O; Weber M; Hartung HP; Steinman L; Zamvil SS
Curr Neurol Neurosci Rep; 2004 May; 4(3):237-44. PubMed ID: 15102350
[TBL] [Abstract][Full Text] [Related]
17. Statins: from cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases.
Ulivieri C; Baldari CT
Pharmacol Res; 2014 Oct; 88():41-52. PubMed ID: 24657239
[TBL] [Abstract][Full Text] [Related]
18. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
[TBL] [Abstract][Full Text] [Related]
19. [Effects of atorvastatin in multiple sclerosis].
Koh CS
Nihon Rinsho; 2003 Aug; 61(8):1455-60. PubMed ID: 12962038
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstacles.
Neuhaus O; Stüve O; Zamvil SS; Hartung HP
CNS Drugs; 2005; 19(10):833-41. PubMed ID: 16185093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
